TENFU (06868) Confirms No Injection of IPO Proceeds to Chinese Subsidiaries by Taiwan Shareholders in H2 2025, Full Compliance with Cross-Strait Investment Regulations

Stock News01-22 17:44

According to an announcement from TENFU (06868), investments by Taiwanese investors (including individuals and enterprises) in the People's Republic of China, whether direct or indirect and conducted through companies they control, are subject to approval from Taiwan's Investment Commission. Under the cross-strait investment regulations, such investments require prior approval from the Investment Commission; however, an exception allows for post-investment filing within six months if the total cumulative investment by all Taiwanese investors in a single Chinese entity does not exceed US$1 million. As disclosed in the prospectus, the company has several Taiwanese founders, namely Mr. Li Ruibe and Mr. Zeng Mingshun, along with 81 original Taiwanese investors, who are required to comply with these regulations when injecting the proceeds from the company's listing on the Main Board of The Stock Exchange of Hong Kong Limited into its Chinese subsidiaries. During the six-month period from July 1, 2025, to December 31, 2025, the company did not inject any listing proceeds into its Chinese subsidiaries. The company is pleased to announce its full compliance with the aforementioned cross-strait investment regulations throughout this period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment